Metraipolis › archive › dc_f5c69b6ea3ec
EIF5A2 acts as a potential marker for prognosis and immunity in human cancers — Europe PMC PMID:40964657
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40964657
- DOI
- 10.1007/s13205-[numero omesso]-w
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T23:17:03.489Z
- SHA-256 of the archived text
23b18e314cd333e7272efce954f38a870411c74b2adf2a681b61d2a53a7ea407- Stable URL of this page
https://metraipolis.com/documento/dc_f5c69b6ea3ec
How to cite
EIF5A2 acts as a potential marker for prognosis and immunity in human cancers — Europe PMC PMID:40964657 — Europe PMC (en), https://europepmc.org/article/MED/40964657 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f5c69b6ea3ec (Metraipolis archive dc_f5c69b6ea3ec, sha256 23b18e314cd333e7272efce954f38a870411c74b2adf2a681b61d2a53a7ea407)
BibTeX
@misc{dcf5c69b6ea3ec,
title = {EIF5A2 acts as a potential marker for prognosis and immunity in human cancers — Europe PMC PMID:40964657},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40964657},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f5c69b6ea3ec; sha256 23b18e314cd333e7272efce954f38a870411c74b2adf2a681b61d2a53a7ea407},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40964657. Agents can read the archived copy with the MCP tool read_document.